2
Total Mentions
2
Documents
14
Connected Entities
Name reference in documents
EFTA00689626
s not indicative of future returns. Price and availability are subject to change without notice. Additional information is available upon request. Avalanche Drops as Gene Therapy Trial Miss High Expectations (1) 2015-06-15 21:36:53.569 GMT (Updates with analyst's comment in fourth paragraph.) By Danielle Bur
EFTA01368453
request. Avalanche Drops as Gene Therapy Trial Miss High Expectations (1) 2015-06.15 21:36:53.569 GMT (Updates with analyst's comment in fourth paragraph.) By Danielle Bur

Roche
OrganizationPharmaceutical company
Regeneron
PersonSurname reference in documents

Bloomberg L.P.
OrganizationAmerican privately held financial, software, data, and media company
Regeneron Pharmaceuticals Inc.
OrganizationOrganization referenced in documents
Danielle Burger
PersonName reference in documents
Gbola Amusa
PersonName reference in documents
Gary Putka
PersonName reference in documents
Avalanche Biotechnologies Inc.
OrganizationOrganization referenced in documents
AVA-101
OrganizationOrganization referenced in documents
Roche Holding AG's
OrganizationOrganization referenced in documents
Lucentis
OrganizationOrganization referenced in documents
Chardan Capital Markets
OrganizationOrganization referenced in documents
Avalanche
OrganizationOrganization referenced in documents
Chalberg
OrganizationOrganization referenced in documents